SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-19-015933
Filing Date
2019-09-03
Accepted
2019-09-03 09:26:42
Documents
1
Period of Report
2019-09-03
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K/A nt10004342x2_8ka.htm 8-K/A 16395
  Complete submission text file 0001140361-19-015933.txt   17605
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36912 | Film No.: 191071049
SIC: 2836 Biological Products, (No Diagnostic Substances)